A growing library of the omega-3 research we're following — summarized and categorized so you can find what matters to you.
In mice, DHA reduced colitis severity by reshaping gut bacteria and strengthening the intestinal barrier, effects that disappeared when gut bacteria were removed.
A review of 9 trials found probiotics, omega-3s, and plant compounds show early but inconsistent promise as add-on nutritional support in schizophrenia.
A review of 27 studies found that people and animals with obesity often have lower levels of inflammation-resolving fatty acid derivatives in fat tissue and blood, especially Resolvin E1.
A new modeling framework shows that small amounts of certain algae products could meet meaningful portions of daily omega-3 intake targets, but real-world consumption remains low and inconsistent.
Seminal plasma from men with testicular germ cell tumors showed distinct metabolite and oxylipin patterns, including four lipid mediators that helped distinguish cancer samples from controls.
This review summarizes evidence that an imbalance between inflammatory lipid signals and the body's natural pro-resolving mediators (including omega-3-derived resolvins, protectins, and maresins) is linked to unresolved inflammation seen in atherosclerosis.
In mice, an EPA-astaxanthin ester compound protected the gut lining from high-fat diet damage by reshaping gut bacteria and increasing beneficial bile acids.
In rats, adolescent omega-3 (DHA/EPA) supplementation reduced PTSD-like fear, anxiety, and depressive behaviors in adulthood, alongside changes in gut bacteria and brain signaling pathways.
Chemotherapy reduced pro-resolving lipid mediators (like those derived from EPA/DHA) and raised inflammatory prostaglandins in mesothelioma patients, correlating with a gene signature linked to survival.